Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis

Abstract Background Alcohol consumption has been associated with an increased risk of cancer-related mortality. It may also negatively impact oncological therapies, potentially leading to impaired effectiveness or an increased risk of treatment-related toxicities. The aim of this systematic review a...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios Fountoukidis, Aglaia Schiza, Daniel Smith, Mukhrizah Othman, Marie Bergman, Johan Ahlgren, Mats Lambe, Sandra Irenaeus, Antonis Valachis
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13694-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850197988031332352
author Georgios Fountoukidis
Aglaia Schiza
Daniel Smith
Mukhrizah Othman
Marie Bergman
Johan Ahlgren
Mats Lambe
Sandra Irenaeus
Antonis Valachis
author_facet Georgios Fountoukidis
Aglaia Schiza
Daniel Smith
Mukhrizah Othman
Marie Bergman
Johan Ahlgren
Mats Lambe
Sandra Irenaeus
Antonis Valachis
author_sort Georgios Fountoukidis
collection DOAJ
description Abstract Background Alcohol consumption has been associated with an increased risk of cancer-related mortality. It may also negatively impact oncological therapies, potentially leading to impaired effectiveness or an increased risk of treatment-related toxicities. The aim of this systematic review and meta-analysis was to examine the current evidence regarding the potential effects of alcohol consumption during cancer treatments on both treatment effectiveness and toxicity, irrespective of cancer type. Methods A comprehensive literature search was performed across three electronic databases (Medline, Web of Science, Cochrane) covering studies from January 1990 to December 2023. Furthermore, a manual search based on the reference lists of the eligible studies was performed to identify additional potentially eligible studies. Studies were eligible if they involved cancer patients and provided data on alcohol consumption during specific oncological treatments, including its effect on treatment outcomes, or compared treatment effectiveness or toxicity between drinkers and non-drinkers. Studies were excluded if they did not meet these criteria, were duplicates, case reports, conference abstracts, or focused only on cancer-specific or overall survival. Only studies using multivariable analyses to examine the association between alcohol consumption and treatment effectiveness or toxicity were included in the pooled analyses. Pooled Hazard Ratios (HRs) or Odds Ratios (ORs) and their corresponding 95% Confidence Intervals (CIs) were calculated using random-effects models. Study quality was assessed by using the Newcastle–Ottawa scale whereas the GRADE approach was applied to rate the certainty of evidence for pooled analyses. Results Out of 6734 studies identified through searching, 38 met the inclusion criteria for pooled analyses. Alcohol consumption during radiotherapy, with or without concomitant chemotherapy, was associated with worse disease-free survival (pooled HR: 2.05; 95% CI: 1.09 – 3.89), although the numerically increased risk for locoregional recurrence did not reach statistically significance (pooled HR: 2.01; 95% CI: 0.76 – 5.36). The potential impact of alcohol consumption on chemotherapy-induced neurotoxicity and acute / delayed nausea was not statistically significant. However, alcohol consumption was associated with a lower risk of overall chemotherapy-induced nausea (OR: 0.69; 95% CI: 0.57, 0.84). Conclusion Our findings suggest that alcohol consumption may have a negative impact on radiotherapy, whereas its potential impact on the effectiveness of systemic oncological therapies (chemotherapy, molecular targeted therapy, immunotherapy, endocrine therapy) has not been adequately studied. Similarly, the current evidence on the potential association between alcohol consumption and treatment-related toxicities is weak, highlighting the need for well-designed prospective studies on this topic.
format Article
id doaj-art-a1eabdca0899416ea73086477cab4ba1
institution OA Journals
issn 1471-2407
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-a1eabdca0899416ea73086477cab4ba12025-08-20T02:12:59ZengBMCBMC Cancer1471-24072025-02-012511910.1186/s12885-025-13694-zEffect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysisGeorgios Fountoukidis0Aglaia Schiza1Daniel Smith2Mukhrizah Othman3Marie Bergman4Johan Ahlgren5Mats Lambe6Sandra Irenaeus7Antonis Valachis8Department of Oncology, Faculty of Medicine and Health, Örebro UniversityDepartment of Oncology, Uppsala University HospitalClinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro UniversityDepartment of Oncology, Faculty of Medicine and Health, Örebro UniversityDepartment of Oncology, Hospital of KarlstadRegional Cancer Centre, Mid-Sweden Health Care RegionRegional Cancer Centre, Mid-Sweden Health Care RegionRegional Cancer Centre, Mid-Sweden Health Care RegionDepartment of Oncology, Faculty of Medicine and Health, Örebro UniversityAbstract Background Alcohol consumption has been associated with an increased risk of cancer-related mortality. It may also negatively impact oncological therapies, potentially leading to impaired effectiveness or an increased risk of treatment-related toxicities. The aim of this systematic review and meta-analysis was to examine the current evidence regarding the potential effects of alcohol consumption during cancer treatments on both treatment effectiveness and toxicity, irrespective of cancer type. Methods A comprehensive literature search was performed across three electronic databases (Medline, Web of Science, Cochrane) covering studies from January 1990 to December 2023. Furthermore, a manual search based on the reference lists of the eligible studies was performed to identify additional potentially eligible studies. Studies were eligible if they involved cancer patients and provided data on alcohol consumption during specific oncological treatments, including its effect on treatment outcomes, or compared treatment effectiveness or toxicity between drinkers and non-drinkers. Studies were excluded if they did not meet these criteria, were duplicates, case reports, conference abstracts, or focused only on cancer-specific or overall survival. Only studies using multivariable analyses to examine the association between alcohol consumption and treatment effectiveness or toxicity were included in the pooled analyses. Pooled Hazard Ratios (HRs) or Odds Ratios (ORs) and their corresponding 95% Confidence Intervals (CIs) were calculated using random-effects models. Study quality was assessed by using the Newcastle–Ottawa scale whereas the GRADE approach was applied to rate the certainty of evidence for pooled analyses. Results Out of 6734 studies identified through searching, 38 met the inclusion criteria for pooled analyses. Alcohol consumption during radiotherapy, with or without concomitant chemotherapy, was associated with worse disease-free survival (pooled HR: 2.05; 95% CI: 1.09 – 3.89), although the numerically increased risk for locoregional recurrence did not reach statistically significance (pooled HR: 2.01; 95% CI: 0.76 – 5.36). The potential impact of alcohol consumption on chemotherapy-induced neurotoxicity and acute / delayed nausea was not statistically significant. However, alcohol consumption was associated with a lower risk of overall chemotherapy-induced nausea (OR: 0.69; 95% CI: 0.57, 0.84). Conclusion Our findings suggest that alcohol consumption may have a negative impact on radiotherapy, whereas its potential impact on the effectiveness of systemic oncological therapies (chemotherapy, molecular targeted therapy, immunotherapy, endocrine therapy) has not been adequately studied. Similarly, the current evidence on the potential association between alcohol consumption and treatment-related toxicities is weak, highlighting the need for well-designed prospective studies on this topic.https://doi.org/10.1186/s12885-025-13694-zAlcohol consumptionCancer treatmentEffectivenessToxicityMeta-analysis
spellingShingle Georgios Fountoukidis
Aglaia Schiza
Daniel Smith
Mukhrizah Othman
Marie Bergman
Johan Ahlgren
Mats Lambe
Sandra Irenaeus
Antonis Valachis
Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
BMC Cancer
Alcohol consumption
Cancer treatment
Effectiveness
Toxicity
Meta-analysis
title Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
title_full Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
title_fullStr Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
title_full_unstemmed Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
title_short Effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer: a systematic review and meta-analysis
title_sort effect of alcohol consumption on oncological treatment effectiveness and toxicity in patients with cancer a systematic review and meta analysis
topic Alcohol consumption
Cancer treatment
Effectiveness
Toxicity
Meta-analysis
url https://doi.org/10.1186/s12885-025-13694-z
work_keys_str_mv AT georgiosfountoukidis effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT aglaiaschiza effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT danielsmith effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT mukhrizahothman effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT mariebergman effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT johanahlgren effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT matslambe effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT sandrairenaeus effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis
AT antonisvalachis effectofalcoholconsumptionononcologicaltreatmenteffectivenessandtoxicityinpatientswithcancerasystematicreviewandmetaanalysis